Update From Recent Trip, and a Sell Recommendation
I spent most of Tuesday on a road trip to Miami with Patrick. While there, we visited Frank Jaksch, CEO of ChromaDex Corp., at the former IVAX Corp. building. If you recall, IVAX is now part of Teva Pharmaceuticals, and Dr. Phillip Frost, Teva's chairman, keeps his offices there. ChromaDex specializes in phytochemicals, or plant-based compounds. It provides laboratory-grade phytochemicals to academic researchers, and it also sells its own retail dietary supplements.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Technology Profits Confidential
With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.